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y 6, 2013.his study sought to determine the clinical predictors and prognostic signiﬁcance of exercise-induced nonsustained
ventricular tachycardia (NSVT) in a large population of asymptomatic volunteers.Background Prior studies have reported variable risk associated with exercise-induced ventricular arrhythmia.Methods Subjects in the BLSA (Baltimore Longitudinal Study of Aging) free of known cardiovascular disease who completed
at least 1 symptom-limited exercise treadmill test between 1977 and 2001 were included. NSVT episodes were
characterized by QRS morphology, duration, and rate. Subjects underwent follow-up clinical evaluation every 2 years.Results The 2,099 subjects (mean age: 52 years; 52.2% male) underwent a mean of 2.7 exercise tests, in which 79
(3.7%) developed NSVT with exercise on at least 1 test. The median duration of NSVT was 3 beats (5 beats in
84%), and the median rate was 175 beats/min. Subjects with (vs. without) NSVT were older (67  12 years vs.
51  17 years, p < 0.0001) and more likely to be male (80% vs. 51%, p < 0.0001) and to have baseline
electrocardiographic abnormalities (50% vs. 17%, p < 0.0001) or ischemic ST-segment changes with exercise (20%
vs. 10%, p ¼ 0.004). Over a mean follow-up of 13.5  7.7 years, 518 deaths (24.6%) occurred. After multivariable
adjustment for age, sex, and coronary risk factors, exercise-induced NSVT was not signiﬁcantly associated with total
mortality (hazard ratio: 1.30; 95% conﬁdence interval: 0.89 to 1.90; p ¼ 0.17).Conclusions Exercise-induced NSVT occurred in nearly 4% of this asymptomatic adult cohort. This ﬁnding increased with age and
was more common in men. After adjustment for clinical variables, exercise-induced NSVT did not independently
increase the risk of total mortality. (J Am Coll Cardiol 2013;62:595–600) ª 2013 by the American College of
Cardiology FoundationA number of studies have examined the predictors
and prognostic signiﬁcance of exercise-induced ventricular
premature depolarizations (VPDs) and nonsustained ventric-
ular tachycardia (NSVT) in subjects with known or suspected
coronary artery disease or other cardiomyopathies (1–4). In
these settings, exercise-induced ventricular arrhythmia has, Department of Medicine, Johns Hopkins
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012; revised manuscript received April 26, 2013,been shown to have an adverse effect on prognosis. However,
the long-term prognostic signiﬁcance of ventricular arrhyth-
mias induced by exercise testing in apparently healthy subjects
is controversial. We previously observed a benign prognosis in
a small number of subjects with exercise-induced NSVT over
2 to 5 years of mean follow-up (5,6). The goal of the present
study is to examine the prevalence, predictors, and prognostic
signiﬁcance of exercise-induced NSVT in a larger cohort of
healthy subjects with long-term follow-up.Methods
The BLSA (Baltimore Longitudinal Study of Aging) is a
prospective study of the aging process that is continuously
enrolling active, generally healthy, community-dwelling
volunteers aged 21 years and older (7). Subjects undergo 2 to
3 days ofmedical, physiological, and psychological testing at the
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596Gerontology Research Center and
the National Institute of Aging
Clinical Research Unit, both in
Baltimore, Maryland, approxi-
mately every 2 years. Treadmill
exercise testing is offered on alter-
nate visits to all individuals without
clinical heart disease or major
noncardiac diseases that would
limit the ability to perform aerobic
exercise.
Between September 1977 and
December 2001, 2,178 subjects
underwent a total of 5,854 maximal exercise treadmill tests
(mean of 2.7 tests per subject). Of these 2,178 subjects, 79
(3.8%) were excluded for various reasons as shown in
Figure 1, leaving 2,099 subjects in the present analysis.
Exercise treadmill testing was performed using a modiﬁed
Balke protocol, during which the treadmill grade was
increased 3% every 2 min, starting from a horizontal posi-
tion; women walked at an initial speed of 3.0 mph and men
at 3.5 mph (8). In more aerobically ﬁt subjects, speed was
increased by 0.5 mph 1 to 3 times during the test. Before
exercise, a standard 12-lead electrocardiogram (ECG) was
recorded with the subject in the supine and seated positions,
after 30 s of forced hyperventilation, and after 30 s of
standing. A 12-lead ECG and brachial artery cuff blood
pressure were recorded every 2 min during exercise, at
maximal effort, immediately after cessation of exercise, and
every 2 min for at least 6 min into recovery. Testing wasudy Flow Diagram
the steps in selection of subjects for inclusion in the
diogram; ETT ¼ exercise tolerance test; MI ¼ myocarterminated because of fatigue, dyspnea, or leg discomfort;
NSVT was not the reason for early exercise termination
unless accompanied by symptoms.
Resting and exercise ECG abnormalities were assessed by
Minnesota Code criteria by a single observer (J.L.F.).
Ischemic ECG changes were coded as previously described
(8). NSVT was deﬁned by the presence of 3 or more
consecutive premature ventricular beats at a rate>100 beats/
min with spontaneous termination within 30 s. Exercise
tests showing NSVT were subsequently reviewed by an
electrophysiologist (J.E.M.) and additional information,
including duration, rate, and ventricular tachycardia (VT)
morphology, was extracted.
Cardiovascular risk factors were assessed for all subjects
at the time of the initial exercise test. Hypertension was
deﬁned by use of antihypertensive drug therapy or
a current blood pressure 140/90 mm Hg, hypercholes-
terolemia was deﬁned by a plasma total cholesterol level
240 mg/dl, diabetes mellitus was deﬁned by the use of
insulin or oral hypoglycemic agents or a fasting plasma
glucose level 126 mg/dl, and current smoking was
deﬁned as 5 cigarettes/day. Body mass index was calcu-
lated as weight in kilograms/(height in meters)2. Mortality
information was obtained via death certiﬁcates and autopsy
reports as available and supplemented by the National
Death Index through December 31, 2006.
The clinical characteristics of the cohort are shown as
mean  SD or percent and compared using the unpaired
t test or chi-square test as appropriate. Univariate predictors
of mortality were obtained using Kaplan-Meier analysis, andstudy analysis. BLSA ¼ Baltimore Longitudinal Study of Aging;
dial infarction.
Figure 2 Prevalence of Exercise-Induced NSVT by Age and Sex
The bar graph shows the prevalence of NSVT observed on at least 1 exercise test
stratiﬁed by decade of age and sex. A marked effect of age on the prevalence of
exercise-induced NSVT was seen in men and to a lesser degree in women. NSVT ¼
nonsustained ventricular tachycardia.
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proportional hazards model. The multivariate model
included NSVT status, age, sex, diabetes, hypertension,
body mass index, smoking status, hypercholesterolemia, any
baseline ECG abnormality, ischemic ST-segment depres-
sion with exercise, and exercise duration. The ﬁnal model
was derived using the backward elimination method. NSVT
status was forced into the model because it was the variable
of interest. Unadjusted and adjusted Kaplan-Meier plots
were constructed to show the difference in the mortality of
the 2 NSVT groups pre- and post-adjustment. The Statis-
tical Analysis System (version 9.1, SAS Institute, Cary,
North Carolina) was used for all analyses. A 2-tailed prob-
ability value <0.05 was required for statistical signiﬁcance.
Results
The ﬁnal cohort included 2,099 subjects (mean age: 52
years; 52.2% male) who underwent a mean of 2.7 tests, and
79 (3.7%) developed NSVT during at least 1 exercise test.
Participant characteristics are shown in Table 1. Subjects
with (vs. without) NSVT were substantially older (age 67 
12 years vs. 51  17 years), were more likely to be male and
hypertensive, and had a modestly higher body mass index.
There were no signiﬁcant differences in the prevalence of
other coronary risk factors. The median duration of NSVT
was 3 beats (5 beats in 84%), and the median rate was 175
beats/min. NSVT was polymorphic in 60% of subjects,
monomorphic in 29%, and indeterminate in 11%; NSVT
occurred during exercise only in 74% of subjects, recovery
only in 20%, and both in 6%. Early termination of exercise
testing because of NSVT was not required in any subject. Of
the 42 individuals who underwent at least one subsequent
exercise test after the test demonstrating NSVT, NSVT
recurred in 12 subjects (29%).
The prevalence of exercise-induced NSVT was 5.7% in
men (63 of 1,095 subjects) and 1.6% in women (16 of 1,004)
(p < 0.0001). As shown in Figure 2, the prevalence of
exercise-induced NSVT increased strikingly with age. Of
note, the age-associated increase in NSVT was much more
prominent in men than in women.Table 1 Clinical Characteristics of Subjects
Characteristic
NSVT
(n ¼ 79)
No NSVT
(n ¼ 2,020) p Value
Age (yrs) 67.0  12 51.4  17 <0.0001
Sex (% men) 63 (79.7) 1033 (51.1) <0.0001
Body mass
index (kg/m2)
26.3  4.8 25.1  4.0 0.03
Ethnicity (% white) 61 (77.2) 1558 (77.1) 0.98
Smoking status
(% current)
3 (3.8) 86 (4.2) 0.84
Hypertension 26 (33) 402 (20) 0.004
Diabetes 3 (3.8) 58 (2.8) 0.63
Hypercholesterolemia 10 (12.6) 373 (18.4) 0.18
Values are mean  SD or n (%).
NSVT ¼ nonsustained ventricular tachycardia.Table 2 compares the resting ECG of subjects with and
without exercise-induced NSVT. Subjects with NSVT were
signiﬁcantly more likely to have ECG abnormalities than
those without NSVT (49.5% vs. 17%, p < 0.0001). Isolated
VPDs, conduction defects other than left bundle branch
block, and minor ST-T changes were signiﬁcantly more
prevalent in subjects with exercise-induced NSVT.
Table 3 shows the exercise testing results. Subjects with
NSVT had lower exercise tolerance and lower peak heart rate
but achieved a similar rate-pressure product and percentage of
age-predicted maximum heart rate compared with those
without NSVT. Ischemic ST-segment changes induced by
exercise were more prevalent in subjects with NSVT (20.2%
vs. 10.2%, p ¼ 0.004). Multivariable predictors of exercise-
induced NSVT were older age (hazard ratio [HR]: 1.04/year;
95% conﬁdence interval [CI]: 1.03 to 1.06; p< 0.0001), male
(HR: 4.9; 95% CI: 2.7 to 9.0; p < 0.0001), VPD on resting
ECG (HR: 4.6; 95%CI: 2.0 to 10.6; p< 0.001), and ischemicTable 2 Baseline Electrocardiographic Characteristics
Characteristic
NSVT
(n ¼ 79)
No NSVT
(n ¼ 2,020) p Value
Atrial PDs 4 (5.1) 56 (2.7) 0.23
Ventricular PDs 10 (12.7) 51 (2.5) <0.0001
First-degree AV block 7 (8.8) 54 (2.6) 0.0013
Left axis deviation 11 (13.9) 96 (4.7) 0.0003
Right bundle branch block 5 (6.3) 25 (1.2) 0.004
Left bundle branch block 0 3 (0.15) 1.00
Minor IVCD 5 (6.3) 62 (3.7) 0.10
Minor ST-T changes 11 (13.9) 109 (5.4) 0.0014
Any of these characteristics 40 (49.5) 368 (17.0) <0.0001
Values are (%).
AV ¼ atrioventricular; IVCD ¼ intraventricular conduction delay; NSVT ¼ nonsustained ventricular
tachycardia; PD ¼ premature depolarization; ST-T ¼ ST-segment–T-wave.
Table 3 Exercise Test Characteristics
Characteristic
NSVT
(n ¼ 79)
No NSVT
(n ¼ 2,020) p Value
Exercise duration
(min)
8.9  2.6 10.6  3 <0.0001
Peak heart rate
(beats/min)
155  17 168  21 <0.0001
Maximum predicted
heart rate (%)
101  9 99  8 0.24
Peak systolic blood
pressure (mm Hg)
187  26 171  28 0.0004
Peak rate-pressure
product (beats/min
 mm Hg)
28,991  5,260 28,918  5,487 0.90
Ischemic ST-segment
changes
16 (20.2) 206 (10.2) 0.0044
Values are mean  SD or n (%).
Abbreviation as in Table 1.
Figure 3
Kaplan-Meier Analysis of Survival Probability
Stratiﬁed by the Presence or Absence of NSVT
(A) Unadjusted survival analysis of study subjects stratiﬁed by the presence or
absence of exercise-induced NSVT. (B) Adjusted survival analysis of study
subjects stratiﬁed by NSVT status, adjusted for the ﬁnal Cox model, which included
NSVT status, age, sex, diabetes, hypertension, body mass index, smoking status,
hypercholesterolemia, any baseline electrocardiographic abnormality, exercise
duration, and ischemic ST-segment depression. Abbreviations as in Figures 1
and 2.
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598ST-segment changes during exercise (HR: 1.8; 95% CI: 1.04
to 3.2; p < 0.05).
Over a mean follow-up of 13.5  7.7 years, 518 subjects
(24.6%) died. The median follow-up of the entire sample was
12.5 years, with a median follow-up of 9.5 years in subjects
with exercise-induced NSVT and 12.7 years in subjects
without this ﬁnding. As shown in Figure 3A, the unadjusted
total mortality rate was higher in subjects with exercise-
induced NSVT than in those without (39% vs. 24%, p <
0.0001). However, after adjustment for baseline demo-
graphic variables and coronary risk factors, the total mortality
rate was not signiﬁcantly different between subjects with
and without exercise-induced NSVT (Fig. 3B). Unadjusted
total mortality rates did not vary signiﬁcantly by morphology
of NSVT or by whether VT occurred on a single test or
multiple tests. Mortality also did not differ signiﬁcantly
between the 74% of subjects with NSVT only during exer-
cise and the 20% with NSVT only in recovery (chi-square
p value ¼ 0.53). In addition, the risk of death was similar
in the 12 subjects who had NSVT on more than 1 visit
compared with the 30 subjects who had NSVT on only
1 visit (chi-square p value ¼ 0.55).
Multivariate determinants of total mortality in a Cox
model that included baseline demographic variables, coro-
nary risk factors, resting ECG, and exercise variables are
shown in Table 4. Older age, male, diabetes, hypertension,
and shorter exercise duration were independent predictors of
total mortality in the cohort. However, the presence of
exercise-induced NSVT was not independently predictive
of mortality.Discussion
In the current analysis, exercise-induced NSVT occurred
on 1 or more tests in 3.7% of asymptomatic community-
dwelling BLSA volunteers who were free of clinical
heart disease on initial testing. The ﬁnding was more prev-
alent in men, older subjects, and those with hypertension.Conduction and repolarization abnormalities and VPDs on
resting ECG and exercise-induced ischemic ST-segment
changes were more frequent in subjects with exercise-induced
NSVT. Although the unadjusted total mortality rate was
higher in subjects with exercise-induced NSVT, this ﬁnding
did not persist after adjustment for baseline clinical character-
istics and was largely explained by differences in age and sex.
In a prior BLSA study, 10 older individuals who were
found to have exercise-induced NSVT had similar coronary
risk factors, exercise tolerance, and ST-segment response
to exercise compared with age- and sex-matched subjects
without NSVT. Over 2 years of mean follow-up, all indi-
viduals remained free of cardiac events (5). In a later study,
subjects with frequent exercise-induced VPDs (n ¼ 62) or
NSVT (n ¼ 18) displayed no difference in the prevalence
Table 4 Multivariable-Adjusted Predictors of Mortality
Variable Hazard Ratio
95% Conﬁdence
Interval for
Hazard Ratio p Value
NSVT 1.30 0.89–1.90 0.17
Age (/yr) 1.11 1.09–1.12 <0.0001
Male 1.75 1.42–2.13 <0.0001
Hypertension 1.51 1.10–2.00 <0.01
Diabetes 2.06 1.37–3.08 0.0005
Exercise duration (/min) 0.91 0.87–0.94 <0.0001
Hazard ratios are indicated after multivariable adjustment for the ﬁnal Cox model, which included
NSVT status, age, sex, diabetes, hypertension, body mass index, smoking status, hypercholester-
olemia, any baseline electrocardiographic abnormality, exercise duration, and ischemic
ST-segment depression.
Abbreviation as in Table 1.
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599of coronary risk factors or exercise-induced ischemia than
age- and sex-matched controls. Over a mean follow-up of
5.6 years, subjects with NSVT had similar cardiovascular
outcomes compared with subjects without NSVT (6). The
present study conﬁrms and extends these ﬁndings in a larger
group of subjects with exercise-induced NSVT, with
comparison to the entire BLSA cohort over a much longer
follow-up.
Most prior studies examining the prognosis of asymp-
tomatic persons with exercise-induced ventricular arrhyth-
mias have focused largely on VPDs rather than NSVT.
Jouven et al. (4) examined the results of exercise testing on
a cohort of 6,101 asymptomatic male French civil servants
aged 42 to 53 years with a mean follow-up of 23 years and
found that frequent VPDs during exercise (deﬁned at 2 or
more consecutive beats or >10% of total beats) predicted
increased total and cardiovascular mortality.
Frolkis et al. (1) reviewed exercise tests on 29,244 patients
undergoing exercise testing for clinical indications (1). They
found that frequent VPDs during exercise (deﬁned as the
presence of 7 or more ventricular premature beats/min
during any given stage, ventricular bigeminy, ventricular
trigeminy, ventricular couplets, ventricular triplets, sustained
or nonsustained VT ventricular ﬂutter, torsades de pointes,
or ventricular ﬁbrillation) predicted increased total mortality
(HR: 1.8) over a mean follow-up of 5.3 years on univariate
analysis. However, after propensity matching for con-
founding variables, only frequent ventricular ectopy during
recovery predicted increased mortality, whereas frequent
ventricular ectopy that occurred during exercise did not.
Eckart et al. examined 585 patients with exercise-induced
ventricular arrhythmia (deﬁned as ventricular couplets,
triplets, or multifocal ventricular ectopy) during clinically
indicated exercise testing and compared outcomes with
2,340 matched control subjects without arrhythmia over
a mean follow-up of 2 years (2). They found that exercise-
induced ventricular arrhythmia with right bundle branch
block morphology or with multiple morphologies predicted
higher mortality. However, patients with left bundle branch
block morphology of ventricular arrhythmia had outcomessimilar to those of matched patients without arrhythmia.
Our study differs in that we examined only asymptomatic
subjects who were free of known cardiac disease. It is likely
that exercise-induced VPDs have greater prognostic signif-
icance in a population with a clinical suspicion and higher
prevalence of coronary artery disease.
Most relevant to the current study, Yang et al. (3) found
that exercise-induced NSVT developed in 50 (1.5%) of
3,351 patients (97% men; mean age: 62 years) undergoing
clinically indicated exercise testing at the Long Beach
Veterans Affairs Medical Center. In 30 of these patients
(60%), the NSVT was 3 beats in duration; NSVT occurred
with nearly equal frequency during exercise (52%) and in
recovery (48%). Only 2 of 26 patients with NSVT who
underwent repeat exercise testing developed NSVT on the
subsequent test. Over a mean follow-up of 26 months, the
unadjusted total mortality rate in the NSVT group (3.6%)
was not signiﬁcantly different than the mortality rate in the
total group (5.1%). Both the clinical characteristics and lack
of prognostic signiﬁcance of the exercise-induced NSVT are
concordant with our ﬁndings, although their follow-up was
of relatively short duration (3).
A noteworthy ﬁnding in the present study was the striking
age-related increase in exercise-induced NSVT, particularly
inmen.The reasons for themarked increase of exercise-induced
NSVT with age are not clear but may relate to age-related
cardiovascular changes. Previous work has demonstrated that
myocyte hypertrophy, increased cardiac matrix connective
tissue, and altered calcium handling occur with aging (9–12).
Moreover, myocyte loss and reactive hypertrophy occur to
a greater degree in men than in women (13). Increased cardiac
beta-receptor stimulation during exercise, as demonstrated by
exaggerated augmentation of plasma catecholamines in older
versus younger men, may contribute to increased ventricular
ectopic activity in this milieu (14).
Our ﬁndings do not negate the risk of exercise-induced
NSVT in patients with coronary artery disease, cardiomyop-
athies, and inherited arrhythmia syndromes. When NSVT
occurs in a milieu of myocardial ﬁbrosis, hypertrophy, or
ischemia, it is a prognostic indicator of adverse events.
Increased risk of sudden death with spontaneous and exercise-
induced NSVT has been demonstrated for patients with
hypertrophic cardiomyopathy (15,16), Chagasic cardiomy-
opathy (17), arrhythmogenic right ventricular dysplasia (18),
and catecholaminergic polymorphic VT (19). Assessing for
such diseases in a patient with exercise-induced NSVT would
therefore be reasonable if clinically suspected. Likewise, our
results do not necessarily suggest that exercise-inducedNSVT
should be disregarded in patients referred for clinically indi-
cated exercise testing. Rather, our ﬁndings suggest that in
older individuals in whom signiﬁcant coronary or other heart
disease is unlikely, the ﬁnding of exercise-induced NSVT
alone, particular brief, asymptomatic runs, does not indicate
an adverse prognosis, require extensive evaluation or medical
treatment, or necessitate exercise restrictions.
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600Study limitations. The BLSA recruits subjects primarily
from a single geographic region of the United States,
and volunteers are self-selected and generally health
conscious and of higher socioeconomic status. Thus, our
ﬁndings require conﬁrmation in a more general population.
The use of antihypertensive medications such as beta-
blockers and calcium channel blockers as well as secular
changes in cardiac risk factors over the long follow-up
period could have affected long-term mortality, although
these factors would affect both the NSVT and control
groups. Our subjects were a volunteer group of apparently
healthy subjects who were exercised using a modiﬁed Balke
protocol, which may limit direct comparison with other
studies that used different populations, treadmill protocols
(1–3), or cycle exercise (4). The modest number of subjects
with exercise-induced NSVT in this study limits the ability to
perform subgroup analysis. Because cause of death could not
be reliably ascertained in all subjects, the current analysis was
limited to total mortality. We therefore cannot exclude the
possibility that the risk of death from ventricular arrhythmia is
higher in subjects with exercise-induced NSVT. Finally,
because the overwhelming majority of NSVT episodes in the
current study were 3 to 5 beats in length, the benign
prognosis may not necessarily apply to persons with longer
NSVT runs.Conclusions
We found that exercise-induced NSVT in asymptomatic
volunteers free of known cardiovascular disease was more
prevalent in older subjects and in men and occurred more
frequently in those with resting ECG abnormalities and with
exercise-induced ischemic ST-segment changes. Although
total mortality was higher in subjects with exercise-induced
NSVT, these ﬁndings were largely explained by differences in
coronary risk factors and other baseline characteristics, partic-
ularly age. Our results suggest that brief asymptomatic runs of
exercise-induced NSVT, in the absence of clinical heart
disease, are not uncommon in older adults and should not
require further medical evaluation, treatment, or restriction of
exercise.Reprint requests and correspondence: Dr. Jerome L. Fleg,
Division of Cardiovascular Sciences, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room 8147, Bethesda,
Maryland 20892. E-mail: ﬂegj@nhlbi.nih.gov.REFERENCES
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